CASI Pharma (CASI) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts CASI Hot Sheet
Join SI Premium – FREE
CASI Pharma (NASDAQ: CASI) reported Q4 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03).
For earnings history and earnings-related data on CASI Pharma (CASI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Charter Communications (CHTR) Tops Q2 EPS by 66c
- ArcelorMittal Q2 2026 analyst consensus: $2.04B EBITDA expected
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
